comparemela.com

Latest Breaking News On - Terry dagnon - Page 1 : comparemela.com

Outlook Therapeutics appoints new head of licensing and M&A (NASDAQ:OTLK)

Outlook Therapeutics appoints new head of licensing and M&A (NASDAQ:OTLK)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Outlook Therapeutics® Announces Strategic Organizational Realignment

Outlook Therapeutics (NASDAQ:OTLK) Earns Overweight Rating from Analysts at Capital One Financial

Capital One Financial assumed coverage on shares of Outlook Therapeutics (NASDAQ:OTLK – Free Report) in a report released on Thursday, MarketBeat Ratings reports. The brokerage issued an overweight rating and a $5.00 target price on the stock. Separately, Guggenheim initiated coverage on Outlook Therapeutics in a research report on Monday, April 3rd. They set a […]

Outlook Therapeutics, Inc to Post FY2024 Earnings of ($0 16) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:OTLK)

Outlook Therapeutics, Inc to Post FY2024 Earnings of ($0 16) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:OTLK)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

FY2023 EPS Estimates for Outlook Therapeutics, Inc Increased by Chardan Capital (NASDAQ:OTLK)

Outlook Therapeutics, Inc. (NASDAQ:OTLK – Get Rating) – Chardan Capital boosted their FY2023 earnings per share estimates for Outlook Therapeutics in a report issued on Tuesday, May 16th. Chardan Capital analyst D. Gataulin now forecasts that the company will post earnings of ($0.18) per share for the year, up from their prior forecast of ($0.25). […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.